BCAX logo

BCAXBicara Therapeutics

$19.97
$0.03
(0.15%)
Today
Updated: 10:15 AM EDT
Reported EarningsMay 11
Mkt Cap$1.31B
Vol45,587.00

About

Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, a first-in-class EGFR/TGF-ß-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
103

Frequently Asked Questions

What is Market Cap of Bicara Therapeutics Inc.?
What is the 52-week high for Bicara Therapeutics Inc.?
What is the 52-week low for Bicara Therapeutics Inc.?
What is Bicara Therapeutics Inc. stock price today?
What was Bicara Therapeutics Inc. stock price yesterday?
What is the PE ratio of Bicara Therapeutics Inc.?
What is the Price-to-Book ratio of Bicara Therapeutics Inc.?
What is the 50-day moving average of Bicara Therapeutics Inc.?
How many employees does Bicara Therapeutics Inc. have?

Advertisement|Remove ads.